DA
David Amsellem Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
40
Avg Return
Past Year
Past Year
0.73%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
75%
Neutral
25%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Reiterated
| $41 |
27%
upside
| 2 | -1.7% |
0
%
| 4 Mar ‘26 1 month ago |
|
|
|
Overweight
Initiated
| $48 |
109%
upside
| 1 | +6.9% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $75 |
25%
upside
| 2 | +7% |
0
%
| 23 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $432 |
22%
upside
| 1 | +6.3% |
0
%
| 18 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $299 |
43%
upside
| 1 | +4% |
0
%
| 18 Feb ‘26 1 month ago |
|
|
|
Neutral
Maintained
| $177 |
0%
downside
| 1 | – |
–
| 9 Feb ‘26 2 months ago |
|
|
|
Neutral
Maintained
| $12 |
18%
downside
| 1 | – |
–
| 28 Jan ‘26 2 months ago |
|